Woong G. Choi

Cheongju-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Prognostic Implications of High Platelet Reactivity According to DAPT Score After Drug-eluting Stent Implantation: Insight from the PTRG-DES Consortium.

Prognostic Implications of High Platelet Reactivity According to DAPT Score After Drug-eluting Stent Implantation: Insight from the PTRG-DES Consortium.

Journal: The American journal of cardiology

Published: April 27, 2026

Consistency Matters: Clopidogrel Monotherapy as Long-term Secondary Prevention Following Percutaneous Coronary Intervention.

Consistency Matters: Clopidogrel Monotherapy as Long-term Secondary Prevention Following Percutaneous Coronary Intervention.

Journal: Korean circulation journal

Published: February 27, 2026

Impact of single-vessel stent length on long-term clinical outcomes in acute myocardial infarction patients treated with drug-eluting stents.

Impact of single-vessel stent length on long-term clinical outcomes in acute myocardial infarction patients treated with drug-eluting stents.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: November 19, 2025

Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.

Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.

Journal: Drug design, development and therapy

Published: November 09, 2025

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation.

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent Implantation.

Journal: Clinical pharmacology and therapeutics

Published: July 30, 2025

Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB).

Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB).

Journal: The American journal of cardiology

Published: November 21, 2024

Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease.

Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease.

Journal: Cells

Published: May 27, 2024

Effect of hemoglobin A1c change on 24-month clinical outcomes in patients with diabetes after acute myocardial infarction.

Effect of hemoglobin A1c change on 24-month clinical outcomes in patients with diabetes after acute myocardial infarction.

Journal: Coronary artery disease

Published: April 29, 2024

Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trial.

Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trial.

Journal: Heart and vessels

Published: March 22, 2024

The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.

The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention.

Journal: Korean circulation journal

Published: September 18, 2023

Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study.

Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study.

Journal: Korean circulation journal

Published: August 21, 2023

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.

Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.

Journal: JAMA cardiology

Published: August 02, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026